RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Fosamax (drug) (INACTIVE)

A collection of news and information related to Fosamax (drug) (INACTIVE) published by this site and its partners.

Top Fosamax (drug) (INACTIVE) Articles see all

Displaying items 1-5
  • What drugs are going generic this year and next

    What drugs are going generic this year and next
    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic Pharmaceutical Association.
  • The hard facts on bones and vitamin D

     The hard facts on bones and vitamin D
    The best way to reduce risk for osteoporosis — a thinning and weakening of the bones — seems to be the subject of ongoing debate. This month brought a fresh round of questions after a report published in the New England Journal of Medicine...

    The Pros and Cons of Prolia

    The Pros and Cons of Prolia
    The U.S. Food and Drug Administration recently approved a new drug for osteoporosis. Amgen's Prolia (denosumab) prevents fractures in postmenopausal women at a rate similar to the most popular drugs on the market — bisphosphonates such as Fosamax,...

    Female Lawyers for Female Cases

    The law aims to protect men and women equally. Yet some types of cases nearly beg for female representation-and don't get it. That's why Karen Barth Menzies, partner at Robinson Calcagnie Robinson Shapiro & Davis, has devoted her career to taking on the...

    Find out which osteoporosis drug is the safest

    Q: Which osteoporosis drug is the safest? I have been told to take Evista, but am hesitant because of the risk of stroke. A: There are a number of drugs available to treat or prevent osteoporosis. There is no single best (or safest) drug. The choice...